CanadaGHK‑Cu and BPC‑157 powders sold by Xenex Laboratories Inc. in Canada (5 g and 50 g formats; GHK‑Cu lots 73417, 73609, 73926, 73927, 74120; BPC‑157 lots 73358, 73580, 73854, 74118, 74119) are affected. They were recalled because the products are unauthorized active pharmaceutical ingredients; owners should verify if their product is affected, consult a healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or safety complaints to Health Canada.
What's being recalled
Depth of recall: Compounding and Community Pharmacies
Companies: Xenex Laboratories Inc., 2440 Conoe Ave., Coquitlam, BC, V3K 6C2.
How to identify it
Product Name: GHK-Cu (5g & 50g); Dosage Form: Powder; Lot numbers: 73417, 73609, 73926, 73927 & 74120
Product Name: BPC-157 (5g & 50g); Dosage Form: Powder; Lot numbers: 73358, 73580, 73854, 74118 & 74119
The hazard
Products sold are unauthorized active pharmaceutical ingredients (APIs).
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)